Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel J H Kenter

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
British Journal of Clinical Pharmacology|October 21, 2018
Is it time to reform oversight of clinical gene therapy in the EU?Marcel J H Kenter
British Journal of Clinical Pharmacology|February 26, 2015
The return of the prodigal son and the extraordinary development route of antibody TGN1412 - lessons for drug development and clinical pharmacologyMarcel J H Kenter, Adam F Cohen
JAMA|September 14, 2021
Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell DiseaseMarcel J H Kenter, Adam F Cohen
Nature Biotechnology|December 29, 2019
Integrating scientific considerations into R&D project valuationSaco J de Visser, Adam F Cohen, Marcel J H Kenter
Nederlands Tijdschrift Voor Geneeskunde|February 20, 2020
[Environmental regulations impede cancer research and treatment]Marcel J H Kenter, J C Clevers, Jan Cornelissen, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 24, 2011
[Patient safety in clinical intervention research]Cecile T M Brekelmans, Marcel J H Kenter, Lex M Bouter, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
British Journal of Clinical Pharmacology|October 21, 2018
Is it time to reform oversight of clinical gene therapy in the EU?Marcel J H Kenter
British Journal of Clinical Pharmacology|February 26, 2015
The return of the prodigal son and the extraordinary development route of antibody TGN1412 - lessons for drug development and clinical pharmacologyMarcel J H Kenter, Adam F Cohen
JAMA|September 14, 2021
Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell DiseaseMarcel J H Kenter, Adam F Cohen
Nature Biotechnology|December 29, 2019
Integrating scientific considerations into R&D project valuationSaco J de Visser, Adam F Cohen, Marcel J H Kenter
Nederlands Tijdschrift Voor Geneeskunde|February 20, 2020
[Environmental regulations impede cancer research and treatment]Marcel J H Kenter, J C Clevers, Jan Cornelissen, et al.
Nederlands Tijdschrift Voor Geneeskunde|February 24, 2011
[Patient safety in clinical intervention research]Cecile T M Brekelmans, Marcel J H Kenter, Lex M Bouter, et al.
Pageof 1